RetinAI optimises and simplifies clinics, research and pharmaceutical workflows to improve healthcare.
RetinAI optimises and simplifies clinics, research and pharmaceutical workflows to improve healthcare. To achieve this goal, the company builds tools to collect, analyze and organize health data, empowering healthcare professionals and patients with automatic image and data analysis supported by advanced machine learning. RetinAI has proprietary technology that provides unforeseen image quality enhancement, as well as automatic analysis of medical data for hospitals, private practitioners, pharmaceutical companies and device manufacturers at similar level of performance as a human would produce.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 11, 2019 | Seed | Fr2.30M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Verve Ventures | — | Seed |